Leading Liquid Biopsy Company, Exosome Diagnostics, Appoints Daniel Zabrowski As Board Member

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, the developer of a leading liquid biopsy platform that enables non-invasive diagnosis of disease states, potentially obviating the need for tissue biopsy, has announced the appointment of Dan Zabrowski PhD, as a member of its Board of Directors.